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Abstract—The corner stone of cancer management is by far 
chemotherapy, unfortunately toxicity and undesired side-effects of 
these antineoplastic approach often limit its usefulness. Recently it 
has been found that certain dye compounds non cytopathogenic per 
sé, in particular porphyrins, can achieve a  cytopathogenic  effect 
when the neoplastic site is subjected to ultrasounds irradiation, this 
technique is referred to as sonodynamic therapy (SDT). Despite the 
promising results, the poor reproducibility of the treatment, due to 
the poor investigation between the ultrasounds field parameters and 
the SDT activity, hampered the development of robust treatment 
protocol. Therefore the aim of this work has been the 
characterization of high intensity ultrasound fields needed to reach 
the SDT activity. First, by an ultrasound generator system, an in vitro 
sonodynamic treatment has been performed on HT-29 cell line, 
previously pre-incubated with 50 µg/mL of aminilevulinic acid, 
therefore a complete characterization of the ultrasound field in 
measurement conditions has been carried out. An ONDA type AIMS 
III scanning tank system with needle hydrophone ONDA type has 
been used and the real energy that hit the cellular culture in the 
burette has been evaluated. During insonation process   the energy 
supplied to the cells has been about 5 10
-6 
J introducing, for the first 
time in the sonodynamic field, a clear parameter of energy supplied 
to the cells. 
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I. INTRODUCTION 
Although ultrasounds affect tissue through a variety of 
mechanisms, the thermal and non-thermal mechanisms are the 
most prominent. The thermal anti-cancer applications of 
ultrasounds, such as high intensity focused ultrasounds 
(HIFU) that produces coagulative necrosis at a precise focal 
point, have been more extensively studied than has the 
therapeutic use of the non-thermal effects of ultrasounds [1]. 
The tissue interactions associated with the non-thermal effects 
of ultrasounds include the direct interaction between 
ultrasounds and the biological membrane, which is able to 
modify cell permeability and to enhance drug bioavailability 
(sonoporation) [2], and the ability to modify the chemical 
properties of particular compounds, known as sonosensitisers 
 
(sonosensitisation) [3]. Recently, sonodynamic therapy (SDT) 
has been proposed as an innovative non-invasive anticancer 
approach to selectively promote the generation of cytotoxic 
species via the excitation of particular chemical compounds, 
known as sonosensitizers, through ultrasound irradiations [4]. 
Although neither component is individually toxic, together 
they initiate a sonodynamic process culminating in the 
generation of highly reactive cytotoxic species such as radicals 
(hydrogen atoms, hydroxyl, alkoxyl and peroxyl radicals) and 
singlet molecular oxygen, which can rapidly  cause 
intracellular damages leading to cell death via apoptosis 
and/or necrosis and/or autophagy [5]. Sonosensitisation is a 
consequence of acoustic cavitation, i.e., the formation of 
gas/vapour-filled nuclei that grow into microbubbles in 
ultrasound-irradiated fluids: under the appropriate irradiation 
conditions (i.e.: when acoustic pressure amplitude is 
sufficiently high), the cavitation microbubbles implode 
violently, causing the temperature and pressure within the 
cavity to increase drastically [6]. Such extreme conditions are 
confined to the vicinity of the microbubble, and they are able 
to trigger cascades of chemical modifications similar to the 
ones occurring during the photodynamic process. 
Sonosensitizers are able to absorb acoustic cavitation energy 
and translate it into the production of reactive species. 
Collapsing microbubbles are known to promote light emission 
(sonoluminescence) [7], and, intriguingly, the majority of the 
compounds showing sonodynamic efficiency also display 
photodynamic activity: taken together, these two evidences led 
to the hypothesis that sonoluminescence plays a key role in the 
transfer of cavitation energy to the sensitizer, and in the 
sonosensitised generation of reactive species. Despite these 
promising characteristics, the scarce reproducibility of the 
treatment parameters and the poor investigation of the 
correlation between the ultrasound field parameters and the 
induced sonodynamic activity hampered the development of 
robust treatment protocol, preventing this approach from 
reaching clinical applications. Introducing a precise acoustic 
characterization of high intensity ultrasound fields needed to 
reach the sonodynamic activity will have a strong impact on 
the development of SDT and applications of power ultrasound 
in medicine. 
D. Cell proliferation assay 
The WST 1 assay (Roche Applied Science, Penzberg, 
Germany) was employed to consider any effects the treatment 
had on the HT-29 cell proliferation. After the  treatments, 2.5 
3 
II. MATERIALS AND METHODS ×  10 cells  were  seeded  in  100  l  of  culture  medium  in 
 
A. Ultrasound generator system 
The ultrasound field is generated by a plane wave 2.54 cm 
transducer in CW mode at f =1.866 MHz connected to an 
Amplified Research type AR 100A250A power amplifier and 
an AGILENT 33250 function generator. A mechanical adaptor 
has been built to connect the 1 cm diameter burette that 
contains the cellular culture. When filled with ultrapure water, 
the adaptor realizes a high reproducibility of measurement 
conditions and distance (17 mm),from transducer to burette 
[8], as shown in Fig. 1. 
replicates (n=8) in 96-well culture plates. WST-1 solution (10 
l) was added at 24, 48, and 72 hours, and the plates were 
incubated at +37°C in 5% CO2 for 1.5 hours. The well 
absorbance was evaluated at 450 and 620 nm in a microplate 
reader (Asys UV340; Biochrom, Cambridge, UK). Cell 
proliferation data were expressed as a percentage of untreated 
cells. 
 
E. Ultrasound field characterization 
A complete characterization of the ultrasound field in the 
same condition in operative mode has been carried out. Both 
the ultrasound power and the spatial distribution of the 
ultrasound pressure p(x,y,t), impinging on the burette surface 
only, have been evaluated [9]. 
The ultrasonic power, P, is calculated according to the 
relation: 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Ultrasound generation System: A) Function generator; B) Amplifier; 
C) Piston like ultrasound transducer; D) Mechanical adaptor; E) Burette 
B. Cell culture 
The HT-29 human colorectal adenocarcinoma cell line 
(ICLC, Interlab Cell Line Collection, Genova, Italy) was 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) 
and supplemented with 10% fetal bovine serum (v/v), 2 mM 
L-glutamine, 100 UI/mL penicillin, 100 µg/mL streptomycin 
and (Sigma, Milano, Italy) in a humidified atmosphere of 5% 
CO2 air at +37°C. The HT-29 was detached using 0.05% 
trypsin-0.02% EDTA solution (Sigma), suspended once again 
in culture medium and  seeded at the  appropriate cell 
concentration for ultrasound exposure. 
 
C. In vitro sonodynamic treatment 
In the  exponential growth  phase  HT-29 cells  was  pre- 
incubated in the dark for 24 hours with aminolevulinic acid 
(ALA, 50 µg/mL), a natural precursor of the sonosensitizer 
protoporphyrin IX (PpIX). The cells were then normalized to 
5 × 10
5  
cells in a polystyrene tube filled with phosphate- 
buffered saline (PBS), pH 7.4, for the ultrasound irradiation. 
The in vitro experiment was performed under a dim light and 
the temperature of the medium was overseen to avoid 
hyperthermia during the experiment (maximum temperature 
recorded was 33°C). 
P u(T )gM (1) 
where: u(T) is the speed of sound in water, g is the gravity 
acceleration, depending on the water temperature, T, and 
M is the mass variation induced  by  the  ultrasound  field 
[10]. 
The uncertainty at measurement conditions is show in TABLE 
I, where: f is the working frequency of the ultrasound 
transducer, T is the temperature of the water vessel, UIN is the 
rms voltage at the transducer input, P is the measured power 
level and U(P) is expanded uncertainty of the power [11]. 
 
TABLE I. 
 
fa T UIN P U(P) 
MHz °C V W % 
1.866 20.8 40.1 0.7 6.0 
 
An ONDA type AIMS III scanning tank system with needle 
hydrophone ONDA type. HNA-0400 and ONDA preamplifier 
type AH-2020 (HI GAIN configuration) has been used to 
characterize the ultrasound field [12], as shown in Fig. 2. 
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Fig. 2. ONDA AIMSII Scanning tank system. 
 
 
III. RESULTS 
 
A. In vitro biological effects of the sonodynamic treatment 
The sonodynamic treatment with the ALA as a pro-drug of 
the sonosensitizer PpIX (50 g/ml for 24 hours) was able to 
significantly decrease the HT-29 cell growth (Fig. 3). 
Noteworthy is the fact that the sonosensitizer and ultrasounds 
alone unaffected the HT-29 cell growth. Indeed, observation 
under the microscope showed a significant increase of necrotic 
cells only in the HT-29 cells treated with ALA  and 
ultrasounds 24 h hours after the treatmets (Fig. 4). 
 
 
Fig. 3. Effect of different treatment conditions on HT-29 cell growth as a 
function of time. HT-29 were treated with US (1.8 MHz for 5 minutes) or 
ALA (50 µg/mL for 24 hours) or both as SDT. Statistically significant 
difference versus untreated cells: ** p < 0.01; *** p < 0.001. 
 
 
Fig. 4. Representative pictures of HT-29 cells 24 hours after  the 
sonodynamic treatment with ALA and US. A) untreated cells; B) cells 
treated with ALA; C) cells treated with US; D) cells treated with ALA and US 
(magnification 10x). 
 
 
 
B. Ultrasound fileds 
The planar scan of the ultrasound field in operating 
conditions (transducer, mechanical adaptor and burette), at 
distance d 80 mm from the transducer surface, is displayed 
in Fig.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Planar scan of the ultrasonic field used during the insonation. 
 
With the aforementioned measurement setup and data 
analysis, the real energy that hit the cellular culture in the 
burette has been evaluated [13]. 
During the 300 s insonation process, with an ultrasound power 
P = 0.7 W, the energy supplied to the cells is about 5 10
-6 
J. 
IV. DISCUSSION 
The capability of measuring, with a low uncertainty, the 
energy released to cells allows the refinement of the technique 
by the modulation of the power during the specified treatment. 
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This capability is even more useful in in vivo experiments, 
where a complete control of ultrasound field parameters is 
essential to limit hyperthermia effects caused the ultrasound 
beam interaction. 
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